Diagnostic biomarkers for stroke: A stroke neurologist's perspective

Clinical Chemistry

Volumn 51, Issue 11, 2005, Pages 2001-2002

  Hill, Michael D ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BRAIN PROTEIN; DJ 1 PROTEIN; NUCLEOSIDE DIPHOSPHATE KINASE A; UNCLASSIFIED DRUG;

BLOOD BRAIN BARRIER; BLOOD SAMPLING; BRAIN HEMORRHAGE; CEREBROSPINAL FLUID; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC PROCEDURE; DIFFUSION WEIGHTED IMAGING; DISEASE SEVERITY; EDITORIAL; HUMAN; SENSITIVITY AND SPECIFICITY; STROKE; SUBARACHNOID HEMORRHAGE; SUBDURAL HEMATOMA; TRANSIENT ISCHEMIC ATTACK;

BIOLOGICAL MARKERS; CEREBROVASCULAR ACCIDENT; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NUCLEOSIDE-DIPHOSPHATE KINASE; ONCOGENE PROTEINS;

EID: 27444446658     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2005.056382     Document Type: Editorial

References (11)

1. Rainer TH, Wong LK, Lam W, Yuen E, Lam NY, Metreweli C, et al. Prognostic use of circulating plasma nucleic acid concentrations in patients with acute stroke. Clin Chem 2003;49:562-9.
2. Reynolds MA, Kirchick HJ, Dahlen JR, Anderberg JM, McPherson PH, Nakamura KK, et al. Early biomarkers of stroke. Clin Chem 2003;49:1733-9.
3. Dambinova SA, Khounteev GA, Izykenova GA, Zavolokov IG, Ilyukhina AY, Skoromets AA. Blood test detecting autoantibodies to n-methyl-d-aspartate neuroreceptors for evaluation of patients with transient ischemic attack and stroke. Clin Chem 2003;49:1752-62.
4. Allard L, Burkhard PR, Lescuyer P, Burgess JA, Walter N, Hochstrasser DF, Sanchez J-C. PARK7 and nucleoside diphosphate kinase A as plasma markers for the early diagnosis of stroke. Clin Chem 2005;51:2043-51.
5. Kidwell CS, Chalela JA, Saver JL, Starkman S, Hill MD, Demchuk AM, et al. Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA 2004;292:1823-30.
6. Hill MD, Buchan AM. Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness study. Can Med Assoc J 2005;172:1307-12.
7. Weir NU, Buchan AM. A study of the workload and effectiveness of a comprehensive acute stroke service. J Neurol Neurosurg Psychiatry 2005;76:863-5.
8. Wardlaw JM, Sandercock PA, Berge E. Thrombolytic therapy with recombinant tissue plasminogen activator for acute ischemic stroke: where do we go from here? A cumulative meta-analysis. Stroke 2003;34:1437-42.
9. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, et al. Recombinant activated factor vii for acute intracerebral hemorrhage. N Engl J Med 2005;352:777-85.
10. Hacke W, Donnan G, Reschi C, Kaste M, von Kummer R, Broderick JP, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004;363:768-74.
11. Foerch C, Otto B, Singer OC, Neumann-Haefelin T, Van B, Berkefeld J, et al. Serum s100b predicts a malignant course of infarction in patients with acute middle cerebral artery occlusion. Stroke 2004;35:2160-4.